Literature DB >> 13696350

Toxic marrow failure after treatment of carcinoma with cytotoxic drugs.

I C CREE.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/toxicology; BONE MARROW/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13696350      PMCID: PMC2097677          DOI: 10.1136/bmj.2.5211.1499

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  A foetal tissue bank; problems and prospects.

Authors:  H E KAY; M CONSTANDOULAKIS
Journal:  Br Med J       Date:  1959-02-28

2.  Irradiation of the entire body and marrow transplantation: some observations and comments.

Authors:  E D THOMAS; H L LOCHTE; J W FERREBEE
Journal:  Blood       Date:  1959-01       Impact factor: 22.113

3.  Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.

Authors:  G WESTBURY; J G HUMBLE; K A NEWTON; M E SKINNER; D E PEGG
Journal:  Lancet       Date:  1959-05-09       Impact factor: 79.321

4.  Toxic marrow failure treated by a homograft of foetal haemopoietic tissue.

Authors:  J B BRIDGES; J M BRIDGES; G J EDELSTYN; A R LYONS; M G NELSON
Journal:  Lancet       Date:  1960-03-19       Impact factor: 79.321

5.  Technique of human bone-marrow transplants.

Authors:  J G HUMBLE; K A NEWTON
Journal:  Lancet       Date:  1958-01-18       Impact factor: 79.321

  5 in total
  3 in total

1.  Thiotepa and breast cancer.

Authors:  B A STOLL
Journal:  Br Med J       Date:  1963-01-05

2.  Thiotepa in treatment of advanced breast cancer.

Authors:  A LYONS; G EDELSTYN
Journal:  Br Med J       Date:  1962-11-17

3.  Thiotepa in the treatment of advanced breast cancer.

Authors:  A R Lyons; G A Edelstyn
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.